about
Prediction of Impaired Performance in Trail Making Test in MCI Patients With Small Vessel Disease Using DTI Data.Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology.Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.The rehabilitation of attention in patients with mild cognitive impairment and brain subcortical vascular changes using the Attention Process Training-II. The RehAtt Study: rationale, design and methodology.Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study.Multimodal MRI classification in vascular mild cognitive impairment.Rapidly progressive cognitive impairment in a patient with high flow dural arteriovenous fistulas, cerebral sinus thrombosis and protein S deficiency.Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt StudyThe burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study.Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.rTMS in resistant mixed states: an exploratory study.Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis.A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient.White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI-Tuscany Study.Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases.Resting state fMRI regional homogeneity correlates with cognition measures in subcortical vascular cognitive impairment.White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.Facial affect recognition in CADASIL patients.The VAS-COG clinic: an out-patient service for patients with cognitive and behavioral consequences of cerebrovascular diseases.Qualitative Evaluation of the Immediate Copy of the Rey-Osterrieth Complex Figure: Comparison Between Vascular and Degenerative MCI Patients.Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: the VMCI-Tuscany Study.Factors predicting the Montreal cognitive assessment (MoCA) applicability and performances in a stroke unit.Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES).The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis.Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes.Whole-brain histogram and voxel-based analyses of diffusion tensor imaging in patients with leukoaraiosis: correlation with motor and cognitive impairment.Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients.DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS studyCerebral small vessel disease and systemic arteriopathy in intracranial arterial dolichoectasia patientsMild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinicPsychophysical Judgment of CurvaturesRelevance of brain lesion location for cognition in vascular mild cognitive impairmentRole of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and MethodologyFunctional magnetic resonance imaging with encoding task in patients with mild cognitive impairment and different severity of leukoaraiosisImpulsivity trait and proactive cognitive control: An fMRI studyFunctional Magnetic Resonance Imaging of Inhibitory Control Reveals Decreased Blood Oxygen Level Dependent Effect in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyAssociation of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial-the CONIVaD trial
P50
Q31056122-BAAED611-46F5-4CE6-9269-20171815A022Q31058235-110A0D0B-0498-42BA-9217-A81D58F8741BQ35895842-11CAB4D3-6EC8-4012-ADD7-15A4A894B32CQ36172526-554E7C66-B53C-43CE-9D0A-CDB2932F859BQ38390608-3E4B60D9-2BD1-4518-8820-CE58B5432B3CQ38436418-6FFC2DF9-22D2-46F5-83CD-E6E4665E9804Q40137935-488796E9-2EFF-4233-B4E1-10B115E5D489Q40184860-62C74992-2860-410B-B099-89FE6902A5F2Q42083636-DCED3FB7-9C57-4149-BECC-BD32239CE96DQ44330962-245BAFEB-98D1-4745-8351-6043B675188CQ44368460-1BC0A7FB-88D0-4F8F-A8C0-B0F0AD574B63Q45292352-1D07F419-790D-4D40-B5B1-EFB30B131CB5Q46006296-63E04FF0-F46A-4535-B152-F4579F1B78CFQ46894124-275E5F9F-7932-40DA-8B9E-92B12A33FE5EQ48072123-5F5A95DA-6C03-460A-B14A-6578C8DC9D8CQ48126640-C6C87351-72E4-4677-8274-27F392A74756Q48137920-D8F319E7-592D-4D8B-86A4-40BD03C1BD68Q48235238-8176795F-2A37-4E4C-9FF9-FF68CE438CB0Q48335640-A71021B5-0DF4-442F-9381-D2098988F1A6Q48456547-B7862366-0AC9-4F9E-BCAA-42999D41CDC2Q48584579-736F751D-CCA3-48A1-9EA2-D667F12EF78DQ48751323-BD95A882-32D1-4E93-AA65-911483A8FD1BQ50114035-25F8DB01-A42C-449C-800E-FF34E4CBF906Q50626394-875DF06C-7D9B-46B8-B185-C6B53D4996E2Q50882364-1D51B2D8-7B7B-4508-A5B5-16888917E2D3Q50891030-483F05E5-AC27-41D9-A652-F98D575EE892Q51321267-D6A4D64D-993B-46DF-A839-CA119A1EC9FAQ51896129-C092AE00-AD65-4241-99D4-9C27590948FEQ51907941-326A5DCB-5ABF-4FF2-93AF-E9585D5DAF6AQ55284993-9C76CFD5-D9D6-472B-91B6-5AE84BF81E85Q56383493-3EF4CDC9-5173-4CA8-9B29-103CF84BDC6EQ58591610-0D9DD9F6-187F-4C22-915A-1924851F0108Q60469196-CE5D6D57-4D1C-4F71-B992-AFB1C7533E4DQ62141756-C5D26686-2723-4836-B02C-C5688CE8F0E7Q64058999-5630A1C5-384C-4186-B70E-FA6B51C409F8Q90241216-66408FA2-9AA3-435F-B9AF-E026187634DDQ90421691-A3DA0058-E5A7-4B2C-863D-676B7C7D3857Q90484707-1A2AE9ED-7C90-4C5E-922A-23D7375B65ABQ90725261-BE811538-BD30-49EB-8E6A-DADA42D7FDC6Q92423600-9BD462F8-FE16-4A29-A834-F6EBE1831420
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emilia Salvadori
@ast
Emilia Salvadori
@en
Emilia Salvadori
@es
Emilia Salvadori
@nl
Emilia Salvadori
@sl
type
label
Emilia Salvadori
@ast
Emilia Salvadori
@en
Emilia Salvadori
@es
Emilia Salvadori
@nl
Emilia Salvadori
@sl
prefLabel
Emilia Salvadori
@ast
Emilia Salvadori
@en
Emilia Salvadori
@es
Emilia Salvadori
@nl
Emilia Salvadori
@sl
P1053
B-1115-2013
P106
P1153
14527949400
P21
P31
P3829
P496
0000-0003-0404-0053